SG11202004260YA - Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives - Google Patents
Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivativesInfo
- Publication number
- SG11202004260YA SG11202004260YA SG11202004260YA SG11202004260YA SG11202004260YA SG 11202004260Y A SG11202004260Y A SG 11202004260YA SG 11202004260Y A SG11202004260Y A SG 11202004260YA SG 11202004260Y A SG11202004260Y A SG 11202004260YA SG 11202004260Y A SG11202004260Y A SG 11202004260YA
- Authority
- SG
- Singapore
- Prior art keywords
- antihelmintic
- quinoline
- amino
- preparing
- carboxamide derivatives
- Prior art date
Links
- BIPPNESAFWTABU-UHFFFAOYSA-N 4-aminoquinoline-3-carboxamide Chemical class C1=CC=CC2=C(N)C(C(=O)N)=CN=C21 BIPPNESAFWTABU-UHFFFAOYSA-N 0.000 title 1
- 230000000507 anthelmentic effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/44—Palladium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17207586 | 2017-12-15 | ||
PCT/EP2018/084964 WO2019115768A1 (en) | 2017-12-15 | 2018-12-14 | Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202004260YA true SG11202004260YA (en) | 2020-06-29 |
Family
ID=60673654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202004260YA SG11202004260YA (en) | 2017-12-15 | 2018-12-14 | Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives |
Country Status (17)
Country | Link |
---|---|
US (1) | US11505544B2 (en) |
EP (1) | EP3692037A1 (en) |
JP (1) | JP7516245B2 (en) |
KR (1) | KR20200099548A (en) |
CN (1) | CN111448192B (en) |
AU (1) | AU2018382999B2 (en) |
CA (1) | CA3085675A1 (en) |
CL (1) | CL2020001589A1 (en) |
CO (1) | CO2020007222A2 (en) |
DO (1) | DOP2020000118A (en) |
IL (1) | IL275216A (en) |
MX (1) | MX2020006185A (en) |
PH (1) | PH12020550905A1 (en) |
SG (1) | SG11202004260YA (en) |
TW (1) | TWI809018B (en) |
UY (1) | UY38009A (en) |
WO (1) | WO2019115768A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102785432B1 (en) | 2018-07-09 | 2025-03-21 | 베링거잉겔하임베트메디카게엠베하 | Antiparasitic heterocyclic compounds |
CA3122106C (en) * | 2018-12-18 | 2024-05-28 | Elanco Tiergesundheit Ag | Bicyclic derivatives |
AR118435A1 (en) | 2019-03-19 | 2021-10-06 | Boehringer Ingelheim Animal Health Usa Inc | AZA-BENZOTHIOPHENE AND AZA-BENZOFURAN COMPOUNDS AS ANTIHELMINTICS |
CA3179528A1 (en) * | 2020-04-09 | 2021-10-14 | Bayer Animal Health Gmbh | Substituted condensed azines as anthelmintic compounds |
CN116249704A (en) | 2020-05-29 | 2023-06-09 | 勃林格殷格翰动物保健美国公司 | Heterocyclic compounds for insect repellent |
EP4148052A1 (en) * | 2021-09-09 | 2023-03-15 | Bayer Animal Health GmbH | New quinoline derivatives |
WO2023073641A1 (en) | 2021-11-01 | 2023-05-04 | Boehringer Ingelheim Vetmedica Gmbh | Anthelmintic pyrrolopyridazine compounds |
KR20240154881A (en) | 2023-04-19 | 2024-10-28 | 오신희 | Support hanger for various facilities with earthquake-proof and damping structure |
WO2025027117A1 (en) | 2023-08-02 | 2025-02-06 | Intervet International B.V. | Carboxamide-4-quinoline compounds with anthelmintic activity |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1128790C (en) * | 1997-12-22 | 2003-11-26 | 法玛西雅厄普约翰美国公司 | 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
MXPA02006474A (en) | 1999-12-28 | 2002-11-29 | Eisai Co Ltd | Heterocyclic compounds having sulfonamide groups. |
CN100356979C (en) | 2000-02-03 | 2007-12-26 | 卫材R&D管理有限公司 | Integrin expression inhibitors |
JP2008214323A (en) | 2007-03-08 | 2008-09-18 | Kyowa Hakko Kogyo Co Ltd | Treating and/or prophylactic agent of skin disease |
AR089939A1 (en) | 2012-02-09 | 2014-10-01 | Glenmark Pharmaceuticals Sa | BICYCLE COMPOUNDS AS INHIBITORS OF mPGES-1 |
AR098475A1 (en) * | 2013-11-26 | 2016-06-01 | Bayer Cropscience Ag | PESTICIDE COMPOUNDS AND USES |
AU2015237050B2 (en) | 2014-03-24 | 2019-05-09 | Guangdong Zhongsheng Pharmaceutical Co., Ltd | Quinoline derivatives as SMO inhibitors |
UY37028A (en) | 2015-12-17 | 2017-07-31 | Astex Therapeutics Ltd | INHIBITING COMPOUNDS OF PROSTAGLANDINA D SINTASA EMATOPOYÉTICA (H-PGDS |
EP3538512B1 (en) * | 2016-11-11 | 2021-06-16 | Bayer Animal Health GmbH | New anthelmintic quinoline-3-carboxamide derivatives |
-
2018
- 2018-12-14 AU AU2018382999A patent/AU2018382999B2/en active Active
- 2018-12-14 WO PCT/EP2018/084964 patent/WO2019115768A1/en active Application Filing
- 2018-12-14 TW TW107145129A patent/TWI809018B/en active
- 2018-12-14 CA CA3085675A patent/CA3085675A1/en active Pending
- 2018-12-14 KR KR1020207020010A patent/KR20200099548A/en active Pending
- 2018-12-14 US US16/772,680 patent/US11505544B2/en active Active
- 2018-12-14 JP JP2020531937A patent/JP7516245B2/en active Active
- 2018-12-14 EP EP18815237.5A patent/EP3692037A1/en active Pending
- 2018-12-14 CN CN201880080813.2A patent/CN111448192B/en active Active
- 2018-12-14 SG SG11202004260YA patent/SG11202004260YA/en unknown
- 2018-12-14 UY UY0001038009A patent/UY38009A/en not_active Application Discontinuation
- 2018-12-14 MX MX2020006185A patent/MX2020006185A/en unknown
-
2020
- 2020-06-08 IL IL275216A patent/IL275216A/en unknown
- 2020-06-12 CO CONC2020/0007222A patent/CO2020007222A2/en unknown
- 2020-06-12 CL CL2020001589A patent/CL2020001589A1/en unknown
- 2020-06-15 DO DO2020000118A patent/DOP2020000118A/en unknown
- 2020-06-15 PH PH12020550905A patent/PH12020550905A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
TWI809018B (en) | 2023-07-21 |
IL275216A (en) | 2020-07-30 |
UY38009A (en) | 2019-07-31 |
CA3085675A1 (en) | 2019-06-20 |
JP7516245B2 (en) | 2024-07-16 |
RU2020123282A (en) | 2022-01-17 |
PH12020550905A1 (en) | 2021-05-17 |
AU2018382999A1 (en) | 2020-05-28 |
MX2020006185A (en) | 2020-09-03 |
US11505544B2 (en) | 2022-11-22 |
CO2020007222A2 (en) | 2020-11-20 |
EP3692037A1 (en) | 2020-08-12 |
DOP2020000118A (en) | 2020-08-31 |
BR112020011901A2 (en) | 2020-11-24 |
KR20200099548A (en) | 2020-08-24 |
CL2020001589A1 (en) | 2020-11-20 |
CN111448192B (en) | 2024-04-12 |
AU2018382999B2 (en) | 2023-11-23 |
WO2019115768A1 (en) | 2019-06-20 |
JP2021506774A (en) | 2021-02-22 |
CN111448192A (en) | 2020-07-24 |
US20200308153A1 (en) | 2020-10-01 |
TW201927773A (en) | 2019-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL275216A (en) | Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives | |
IL274439A (en) | Process for preparing tapinarof | |
ZA201708142B (en) | Process for preparing 4-amino-pyridazines | |
HUE059158T2 (en) | Process for preparing pridopidine | |
IL292429B1 (en) | Improved process for preparing aminopyrimidine derivatives | |
PT3429998T (en) | Process for preparing quinolin-2-yl-phenylamine derivatives and their salts | |
PL3526229T3 (en) | Process for preparing glucopyranosyl-substituted benzyl-benzene derivatives | |
HUE053818T2 (en) | Process for preparing hmf | |
HK1245792A1 (en) | Process for preparing alpha-carboxamide pyrrolidine derivatives | |
IL253877A0 (en) | Process for preparing 3-chloro-2-vinylphenylsulfonates | |
IL268784B (en) | Process for preparing bromotrichloromethane | |
IL248565A0 (en) | Process for preparing thiazole derivatives | |
PL3573988T3 (en) | Process for preparing purine derivatives | |
IL271512B (en) | Method for preparing substituted 4-aminoindane derivatives | |
ZA201908452B (en) | Improved process for preparing imetelstat | |
IL248568A0 (en) | Process for preparing dihydroisoxazole derivatives | |
IL273695A (en) | Process for preparing spiro derivatives | |
IL273639A (en) | Process for preparing alpha-carboxamide pyrolidine derivatives | |
IL253630A0 (en) | Process for preparing substituted phenylisoxazoline derivatives | |
ZA201807441B (en) | Process for preparing oxathiazin-like compounds | |
GB201709297D0 (en) | Method for preparing methylprrolidones | |
HUP1700275A2 (en) | Process for self-host | |
GB201414880D0 (en) | Process for making phosphate derivatives |